Cargando…
Genome-wide approaches to antidepressant treatment: working towards understanding and predicting response
Antidepressants are among the most commonly prescribed drugs, and a range of medications are available. However, treatment response to a particular drug varies greatly between patients, with only 30% of patients responding well to the first treatment administered. Given evidence that antidepressant...
Autores principales: | Hodgson, Karen, Mufti, Shaista Jeelani, Uher, Rudolf, McGuffin, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698532/ https://www.ncbi.nlm.nih.gov/pubmed/22738351 http://dx.doi.org/10.1186/gm351 |
Ejemplares similares
-
DNA methylation in interleukin-11 predicts clinical response to antidepressants in GENDEP
por: Powell, T R, et al.
Publicado: (2013) -
Antidepressant drug-specific prediction of depression treatment outcomes from genetic and clinical variables
por: Iniesta, Raquel, et al.
Publicado: (2018) -
The genome‐wide expression effects of escitalopram and its relationship to neurogenesis, hippocampal volume, and antidepressant response
por: Powell, Timothy R., et al.
Publicado: (2017) -
Exploring the role of drug-metabolising enzymes in antidepressant side effects
por: Hodgson, Karen, et al.
Publicado: (2015) -
Candidate Genes Expression Profile Associated with Antidepressants Response in the GENDEP Study: Differentiating between Baseline ‘Predictors' and Longitudinal ‘Targets'
por: Cattaneo, Annamaria, et al.
Publicado: (2013)